Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells.
Saved in:
| Title: | Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells. |
|---|---|
| Authors: | Jeong JH; Curocell Inc., Daejeon 34002, Republic of Korea., Seo YR; Curocell Inc., Daejeon 34002, Republic of Korea., Yu SR; Curocell Inc., Daejeon 34002, Republic of Korea., Lee HB; Curocell Inc., Daejeon 34002, Republic of Korea., Lee HJ; Curocell Inc., Daejeon 34002, Republic of Korea., Cho HJ; Curocell Inc., Daejeon 34002, Republic of Korea., Kim HC; Curocell Inc., Daejeon 34002, Republic of Korea., Lee YH; Curocell Inc., Daejeon 34002, Republic of Korea. |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2026 Feb 18; Vol. 34 (1), pp. 201158. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2950-3299 |
|---|---|
| DOI: | 10.1016/j.omton.2026.201158 |
